France Prepares 'Kill Pill' Protocols for Assisted Dying Law

As France prepares to vote on its end-of-life law, the Ministry of Health has initiated preparatory work to define the practical application of assisted dying. The High Authority for Health (HAS) has been commissioned to investigate the specific lethal product, often referred to as a "kill pill," that could be used once the law is enacted.

This proactive step aims to address the numerous questions surrounding the implementation of the law. Beyond identifying the suitable product, the HAS experts will also develop recommendations concerning the medical prescription and administration protocols for these substances. The goal is to ensure a safe and controlled process for those eligible under the new legislation.

To achieve this, the HAS will convene a diverse panel of experts. This group will include professionals from various medical fields such as critical care, geriatrics, and general medicine, alongside pharmacists from hospital and community settings, and pharmacologists. Input from healthcare system users will also be incorporated to ensure patient perspectives are considered.

This detailed planning underscores the government's commitment to a thorough and considered rollout of the end-of-life law. By addressing the technical and medical aspects in advance, France seeks to provide clarity and establish a robust framework for assisted dying, drawing lessons from practices in countries like the Netherlands, Belgium, and Canada.